|
|
||||||||
Journal of Lipid Research, Vol 35, 2094-2099, Copyright © 1994 by Lipid Research, Inc.
RE Morton and DJ Greene
Lipid transfer inhibitor protein (LTIP) activity has been typically
quantitated by its ability to suppress lipid transfer protein-mediated
lipid movement between low density lipoprotein (LDL) and high density
lipoprotein (HDL). In an attempt to establish an LTIP activity assay that
is more sensitive, we have exploited the reported preference of the
inhibitor protein to interact with LDL. A lipid transfer assay was
established that involves LDL as both the donor and the acceptor; LDL in
one of these two pools was biotinylated to facilitate its removal with
immobilized avidin. Compared to the standard LDL to HDL assay, LTIP
inhibited lipid transfer from radiolabeled LDL to biotin-LDL 7- fold more.
In the absence of LTIP, lipid transfer activity was the same in both
assays. An added benefit of this assay was the near linearity (up to 85%)
of the inhibitory response, in contrast to the highly curvilinear response
of LTIP in LDL to HDL transfer assays. The high sensitivity of the LDL to
biotin-LDL transfer assay in measuring LTIP activity could not be
duplicated by other transfer assays including assays containing only HDL
(HDL to biotin-HDL), assays between liposomes and LDL, or assays between
LDL and HDL where the concentration of lipoproteins was reduced 10-fold.
Thus, LTIP activity is most effectively measured in homologous lipid
transfer assays involving only LDL (and its biotin derivative). This
increased sensitivity to LTIP suggests that the inhibitor binds more avidly
to the LDL surface than does lipid transfer protein.
ARTICLES
Enhanced detection of lipid transfer inhibitor protein activity by an assay involving only low density lipoprotein
Department of Cell Biology, Cleveland Clinic Foundation, OH 44195.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. E. Morton and D. J. Greene CETP and lipid transfer inhibitor protein are uniquely affected by the negative charge density of the lipid and protein domains of LDL J. Lipid Res., December 1, 2003; 44(12): 2287 - 2296. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Paromov and R. E. Morton Lipid Transfer Inhibitor Protein Defines the Participation of High Density Lipoprotein Subfractions in Lipid Transfer Reactions Mediated by Cholesterol Ester Transfer Protein (CETP) J. Biol. Chem., October 17, 2003; 278(42): 40859 - 40866. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Morton, V. Nunes, L. Izem, and E. Quintao Markedly Elevated Lipid Transfer Inhibitor Protein in Hypercholesterolemic Subjects Is Mitigated by Plasma Triglyceride Levels Arterioscler. Thromb. Vasc. Biol., October 1, 2001; 21(10): 1642 - 1649. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Serdyuk and R. E. Morton Lipid Transfer Inhibitor Protein Defines the Participation of Lipoproteins in Lipid Transfer Reactions : CETP Has No Preference for Cholesteryl Esters in HDL Versus LDL Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 718 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, D. M. Driscoll, and R. E. Morton Molecular Cloning and Expression of Lipid Transfer Inhibitor Protein Reveals Its Identity with Apolipoprotein F J. Biol. Chem., January 15, 1999; 274(3): 1814 - 1820. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Masson, N. Duverger, F. Emmanuel, and L. Lagrost Differential Interaction of the Human Cholesteryl Ester Transfer Protein with Plasma High Density Lipoproteins (HDLs) from Humans, Control Mice, and Transgenic Mice to Human HDL Apolipoproteins. LACK OF LIPID TRANSFER INHIBITORY ACTIVITY IN TRANSGENIC MICE EXPRESSING HUMAN apoA-I J. Biol. Chem., September 26, 1997; 272(39): 24287 - 24293. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |